Fogorvosi szemle, 2012 (105. évfolyam, 1-4. szám)

2012-03-01 / 1. szám

40 FOGORVOSI SZEMLE 105. évf. 1. sz. 2012. a készítményeket más, helyileg ható immun-moduláns készítményekkel, illetve retinoidokkal egészíthetjük ki. Szisztémás kezelésre csak ritkán kerül sor. Az összes (nem specifikus) kezelési módszer célja a gyulladás csökkentése. Hatékony, célzott kezelésre a kórkép ala­posabb megismerése után nyílik majd lehetőség. A tü­netek enyhítése mellett a legfontosabb a diszplasztikus elváltozások kiszűrése, a malignus folyamatok korai ke­zelése. Irodalom 1. Albrecht M, Bánóczy J, Dinya E, Tamás G jr.: Occurrence of oral leukoplakia and lichen planus in diabetes mellitus. J Oral Pathol Med 1992; 21: 364-366. 2. Al Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Miglio­­rati CA et al: Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Oral Pathol Oral Radiol Endod 2003; 95: 291-299. 3. Andreasen JO: Oral lichen planus. I. A clinical evaluation of 115 cas­es. Oral Surg Oral Med Oral Pathol 1968; 25: 36-42. 4. Andreasen JO: Oral lichen planus. II. A histologic evaluation of 97 cases. Oral Surg 1968; 25: 158-166. 5. Axell T, Rundquist L: Oral lichen planus - a demographic study. Comm Dent Oral Epidemiol 1987; 15: 52-56. 6. Azevedo RS, Romanach MJ, de Almeida OP, Mosqueda-Taylor A, Vega-Memije ME, Carlos-Bregni R et al: Lichen sclerosus of the oral mucosa: clinicopathological features of six cases. Int J Oral Maxillo­­fac Surg 2009; 38: 855-860. 7. Bagan Sebastian JV, Milian Masanet MA, Penarrocha Diago M, Jimenez Y: A clinical study of 205 patients with oral lichen planus. J Oral Maxillofac Surg 1992; 50: 116-118. 8. Bán Á: A kapszaicin-érzékeny idegvégződések és a tranziens re­ceptor potenciál vanilloid 1 (TRPV1) receptor szerepe az orális li­chen planus patomechanizmusában. Ph.D. Doktori Tézisek, Pécsi Tudományegyetem, Gyógyszertudományok Doktori Iskola, 2010. 9. Bánóczy J: A szájüregi elváltozások diagnosztikája. LÁM2008; 18: 137-140. 10. Bermejo-Fenoll A, Lopez-Jornet P: Familial oral lichen planus: presentation of six families. Oral Surg Oral Med Oral Oral Pathol Oral Radiol Endod 2006; 102: 12-15. 11. Borghelli RF, Pettianari IL, Chuchurru JA, Stirparo MA: Oral li­chen planus in patients with diabetes. An epidemiologic study. Oral Surg Oral Med Oral Pathol 1993; 75: 498-500. 12. Bouqout JE, Gorlin E: Leukoplakia, lichen planus, and other ker­atoses in 23,616 white americans over the age of 35 years. Oral Surg 1986; 61: 373-381. 13. Bouquot JE Gundlach KK: Oral exophytic lesions in 23,616 white Americans over 35 years of age. Oral Surg Oral Med Oral Pathol 1986;62:284-291. 14. Brant JMC, Vasconsielos AC, Rodrigues LV: Role of apoptosis in erosive and reticular oral lichen planus exhibiting variable epithelial thickness. BrazDentJ 2008; 19: 179-185. 15. Campisi G, Giovanelli L, Arico P, Lama A, Di Liberto C, Ammatuna P et al; HPV DNA in clinically different variants of oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Oral Pathol Oral Radiol En­dod 2004; 98: 705-711. 16. Carbone M, Goss E, Carozzo M, Castellano S, Conrotto D, Broc­­coletti R, Gandolfo S: Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow up. J Oral Pathol Med 2003; 32: 323-329. 17. Carozzo M, Gandolfo S, Carbone M, Colombatto P, Broccoletti R, Grazino Demo P et al: Hepatitis C virus infection in italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 1996; 25: 527-533. 18. Carozzo M, Gandolfo S: The management of oral lichen planus. Oral Dis 1999; 5:196-205. 19. Carrozzo M, Gandolfo S: Oral diseases possibly associated with hepatitis C virus. Crit Oral Biol Med 2003; 14: 115-127. 20. Carozzo M, Uboldi di Capei M, Dametto E, Fasano ME, Arduino P, Broccoletti R et al: T umor necrosis factor-alpha and interferon-gam­ma polymorphismus contribute to suspectibility to oral lichen planus. J Invest Dermatol 2004; 122: 87-94. 21. Carozzo M: Oral diseases associated with hepatitis C virus in­fection. Part 2: lichen planus and other diseases. Oral Dis 2008; 14: 217-228. 22. Carozzo M, Thorpe R: Oral lichen planus: a review. Minerva Stomatol 2009; 58: 519-537. 23. Chen C, Chin-Chen P, Chih K, Chih-Pei L: Risk of Oral Nonmalig­­nant Lesions Associated with Human Papillomavirus Infection, Betel Quid Chewing, and Cigarette Smoking in Taiwan. Arch Pathol Med 2006; 130: 57-61. 24. Cox M, Maitland N, Scully C: Human herpes simplex-1 and pap­illomavirus type 16 homologous DNA sequences in normal potential­ly malignant and malignant oral mucosa. Eur J Cancer B Oral Oncol 1993; 29B: 215-219. 25. Crincoli V, Di Bisceglie MB, Scivetti M, Lucchese, Tecco S, Fes­ta F: Oral lichen planus: update on etiopatogenesis, diagnosis and treatment. Review article. Immunopharmacol Immunotoxicol 2011; 33: 11-20. 26. De Jong W F, Albrecht M, Bánóczy J, van der Waal I: Epithelial dysplasia in oral lichen planus. A preliminary report of a Dutch-Hun­­garian study of 100 cases. Int J Oral Surg 1984; 13: 221-225. 27. Ding G, Wang W, Liu Y, Zhang C, Wang S: Mesenchymal stem cell transplantation: a potential therapy for oral lichen planus. Med Hypoth 2011 ; 76: 322-324. 28. Eisen D: The evaluation of cutaneous, genital, scalp, nail, esoph­ageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 431-436. 29. Eisen D: The clinical features, malignant potential and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 2002; 46: 207-214. 30. Eisen D, Carrozzo M, Bagan Sebastian JV, Thongprasom K: Mu­cosal disease series. Number V. Oral lichen planus: clinical features and management. Oral Dis 2005; 11: 338-349. 31. Eisenberg E, Krutchkoff DJ: Lichenoid lesions of oral mucosa. Diagnostic criteria and their importance in the alleged relationship to oral cancer. Oral Surg Oral Med Oral Pathol 1992; 73: 699-704. 32. Eisenberg E: Oral lichen planus: a benign lesion. J Oral Maxillofac Surg 2000; 58: 1278-1285. 33. Firth NA, Rich AM, Radden BG, Reade PC: Assesment of the val­ue of immunofluorescence microscopy in the diagnosis of oral muc­osal lichen planus. J Oral Pathol Med 1990; 19: 890-894. 34. Gandolfo S, Richiardi L, Carozzo M: Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow up study in an Italian population. Oral Oncol2004; 40: 77-83. 35. Helm TN, Camisa C, Liu AY, Valenzuela R, Bergfeld WF: Lichen planus associated with neoplasia: a cell-mediated immune response to tumor antigens? J Am Acad Dermatol 1994; 30: 219-224. 36. Howell FV, Rick GM: Oral lichen planus and diabetes, a potential syndrome. J Calif Dent Assoc 1973; 1: 58-59. 37. Ismail SB, Kumar SKS, Zain RB: Oral lichen and lichenoid reac­tions: etiopatogenesis, diagnosis, management and malignant trans­formation. J Oral Sei 2007; 49: 89-106. 38. Jansen CT, Lehtinen R, Happonen RP, Lehtinen A, Soderlund K: Mouth PUVA: new treatment for recalcitrant oral lichen planus. Pho­­todermatol 1987; 4: 165-166. 39. Johnson H, Soldano CA, Kovich O, Long W: Oral lichen planus. Dermatology Online Journal 2008] 14: 20. 40. Kövesi G: Evaluation of clinical data and immuno-modulating treatment of patients with oral lichen planus. Fogorv Szle 2001; 94: 9-14. 41. Krutchkoff DJ, Cutler L, Laskowski S: Oral lichen planus: the evidence regarding potential malignant transformation. J Oral Pathol 1978; 7: 1-7. 42. Krutchkoff DJ, Eisenberg E. Lichenoid dysplasia: A distinct histo­pathologic entity. Oral Surg Oral Med Oral Pathol 1985; 60: 308-315.

Next

/
  • Layout
  • Zoom
  • Rotation
Thumbnails
Contents